protocols on primary human cells, allowing the mechanism of action & translational relevance of a drug to be defined very early on in the development process.

MesenFlow Technologies has recently extended this technology for use in cosmetics and nutrition. By using their technology, it is possible to explore the physiological impact of a cosmetic or nutraceutical candidate in the early development phase. Their services are particularly tailored to business environments where animal-free testing is mandatory, and an understanding of impact on human biology is paramount.